<DOC>
	<DOCNO>NCT02050100</DOCNO>
	<brief_summary>The study goal collect blood sample individual risk lung cancer order identify protein marker diagnosis lung cancer Chinese population .</brief_summary>
	<brief_title>Biomarkers Diagnosis Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Adults â‰¥ 18 year age Patients referred pulmonologists , oncologist , thoracic surgeon diagnosis suspicious pulmonary nodule either lung cancer benign undergo bronchoscopic biopsy Patients enrol result bronchoscopic biopsy diagnosis NSCLC benign pulmonary nodule Cases : Patients untreated nonsmall cell lung cancer , i.e . primary lung adenocarcinoma squamous cell carcinoma early Computed tomography XRay available show suspicious pulmonary nodule A biopsy surgical resection clarify nature lung nodule available ( NSCLC benign , include histological diagnosis ) group Controls : Patients must available 6 month followup confirm benign diagnosis A serum plasma sample collect prior treatment lung nodule beyond biopsy No cancer diagnosis last 5 year exclude nonmelanoma skin cancer Patients must fully inform investigational nature procedure sign inform consent . Prior treatment lung cancer chemotherapy surgery ( exclude biopsy ) Patients benign nodule able willing 6month followup visit confirm benign diagnosis Diagnosis treatment cancer last 5 year exclude nonmelanoma skin cancer . In judgment clinical investigator , patient likely non compliant uncooperative study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>primary lung adenocarcinoma Stages I , II , IIIA , IIIB</keyword>
	<keyword>squamous cell carcinoma Stages I , II , IIIA , IIIB</keyword>
	<keyword>benign non-calcified pulmonary nodule</keyword>
	<keyword>early detection</keyword>
</DOC>